Monarch Medical Technologies, a Glooko Company

Charlotte, NC, USA  All United States companies → — Founded 2003
Healthcare Analytics / BI Specialty-Focused AI
Acquired

Products

EndoTool SubQ
Monarch Medical Technologies, a Glooko Company
Endocrinology & Metabolic AI
EndoTool SubQ provides clinical decision support for any situation where subcutaneous insulin is administered to all patient types, including pediatrics. This proprietary technology models, predicts and adjusts to each patient's unique physiology and individual response to insulin.

See all 1 product →

About Monarch Medical Technologies, a Glooko Company

Monarch Medical Technologies, a Glooko Company, specializes in insulin management technology for healthcare enterprises. Their flagship product, EndoTool, is a patient-specific insulin dosing system designed for hospitals. It utilizes a precision dosing algorithm to provide recommendations for both intravenous and subcutaneous insulin delivery, aiming to ensure safe and effective management for patients, including those at high risk of hypoglycemia.

The EndoTool system also offers insights and analytics into a hospital’s glycemic outcomes and delivers critical clinical alerts and workflow notifications to enhance patient monitoring. The company’s focus for over two decades has been to empower nurses with a simplified process for insulin management and to support hospitals in enhancing patient safety. Monarch Medical Technologies is now part of Glooko, a global leader in diabetes management, expanding their shared commitment to improving outcomes across the continuum of care.

Focus Areas

Inpatient glycemic management precision insulin dosing clinical decision support diabetes management patient safety EMR interoperability HL7 integration clinical analytics quality measurement for glycemic outcomes

Business Intelligence

TechnologyPredictive, computer-based applications; patient-specific algorithm; model predictive control technology

What Physicians Need to Know

Specialization
Inpatient glycemic management, patient-specific insulin dosing for intravenous and subcutaneous delivery.
Key Differentiator
Patient-specific algorithm that predicts each patient's response to insulin, ensuring safe and effective management, even for those at high risk of hypoglycemia.
Technology Focus
Precision dosing algorithm, insights and analytics for glycemic outcomes, critical clinical alerts and workflow notifications.
Experience
Over two decades leading in insulin management technology, with 3,800 dosing calculations daily.
Clinical Expertise
Guided by a clinical advisory board with over 190 years of combined expertise from physicians in endocrinology, pulmonology, and medical research.
Physician Tip

EndoTool provides precise, patient-specific insulin dosing recommendations, aiming to enhance patient safety by predicting individual responses and reducing hypoglycemia risk. The system offers instant insights into glycemic outcomes and delivers critical clinical alerts, supporting confident insulin management and improved patient monitoring.

Integrating EndoTool into existing hospital systems and workflows involves critical care teams, clinicians, pharmacy staff, IT professionals, diabetes educators, and providers.

Products by Monarch Medical Technologies, a Glooko Company

1 product in the directory

EndoTool SubQ
Monarch Medical Technologies, a Glooko Company
Endocrinology & Metabolic AI
EndoTool SubQ provides clinical decision support for any situation where subcutaneous insulin is administered to all patient types, including pediatrics. This proprietary technology models, predicts and adjusts to each patient's unique physiology and individual response to insulin.

Videos

News, demos, and interviews about Monarch Medical Technologies, a Glooko Company.

Loading videos...

Videos load interactively. If none appear, search YouTube for Monarch Medical Technologies, a Glooko Company →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

EndoTool is a patient-specific insulin dosing system designed for hospitals. It utilizes a patient-specific algorithm to provide precise insulin dosing recommendations for both intravenous and subcutaneous delivery, aiming to ensure safe and effective management while minimizing hypoglycemia risk.
EndoTool's algorithm predicts each patient's response to insulin, delivering precise dosing recommendations. It also provides critical clinical alerts and workflow notifications through its advisories feature to enhance patient monitoring and support clinical decision-making.
Yes, EndoTool provides instant insights into a hospital's glycemic outcomes. This feature allows healthcare providers to gain a quick understanding of their glycemic management performance.
Monarch Medical Technologies' algorithm for EndoTool is patient-specific and designed to predict individual responses to insulin. This approach aims to ensure safe and effective management, particularly for patients at high risk of hypoglycemia.
Yes, EndoTool is an FDA-cleared Class II medical device. It is indicated for inpatient use as described in its Instructions for Use.
While specific details on implementation and workflow optimization processes are not fully detailed, testimonials suggest that integrating EndoTool involves concerted efforts with critical care teams, clinicians, pharmacy staff, IT professionals, diabetes educators, and providers.

Related Companies

CompuGroup Medical is a leading software and e-health provider for doctors, hospitals, community health centers, laboratories, and more. The company offers a comprehensive suite of solutions that support the entire patient journey, from online scheduling and digital intake to AI-powered electronic health record (EHR) documentation, e-prescribing, lab connectivity, telehealth, remote patient monitoring, and revenue cycle […]

AiHealth Clinic is a precision metabolic medicine practice and platform based in Bengaluru, India, specializing in diabetes and obesity care. It offers a continuous intelligence approach, moving beyond traditional three-month snapshots of metabolic health. The clinic utilizes continuous glucose monitoring (CGM), GLP-1/GIP therapies, and proprietary AI-driven scoring engines (MMIQ for metabolic health and BMIQ for […]

90Health offers a comprehensive digital solution for managing chronic diseases, aiming to address the significant financial burden these conditions place on the U.S. healthcare system. Their platform integrates AI-powered digital programs with human support to facilitate behavior change and improve patient outcomes. The solution includes access to evidence-based cognitive behavioral lessons designed to help patients […]

The SafeCare Group is an AI-driven healthcare technology company focused on enhancing healthcare outcomes by intelligently utilizing electronic medical record (EMR) data. Their SafeCare AI® platform, also known as SafeCare Applied Intelligence®, has been operational since 2016. It integrates intelligence capabilities to predict healthcare outcomes and identify opportunities to intervene, helping hospitals allocate limited clinical […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.